Mechanochemical endovenous Ablation versus RADiOfrequeNcy Ablation in the treatment of primary great saphenous vein incompetence (MARADONA): study protocol for a randomized controlled trial

Ramon R J P van Eekeren, Doeke Boersma, Suzanne Holewijn, Anco Vahl, Jean Paul p m de Vries, Clark J Zeebregts, Michel M P J Reijnen, Ramon R J P van Eekeren, Doeke Boersma, Suzanne Holewijn, Anco Vahl, Jean Paul p m de Vries, Clark J Zeebregts, Michel M P J Reijnen

Abstract

Background: Radiofrequency ablation (RFA) is associated with an excellent outcome in the treatment of great saphenous vein (GSV) incompetence. The use of thermal energy as a treatment source requires the instillation of tumescence anesthesia. Mechanochemical endovenous ablation (MOCA) combines mechanical endothelial damage, using a rotating wire, with the infusion of a liquid sclerosant. Tumescence anesthesia is not required. Preliminary experiences with MOCA showed good results and low post-procedural pain.

Methods/design: The MARADONA (Mechanochemical endovenous Ablation versus RADiOfrequeNcy Ablation) trial is a multicenter randomized controlled trial in which 460 patients will be randomly allocated to MOCA or RFA. All patients with primary GSV incompetence who meet the eligibility criteria will be invited to participate in this trial. The primary endpoints are anatomic and clinical success at a one-year follow-up, and post-procedural pain. The secondary endpoints are technical success, complications, operation time, procedural pain, disease-specific quality of life, time taken to return to daily activities and/or work, and cost-efficiency analyses after RFA or MOCA. Both groups will be evaluated on an intention to treat base.

Discussion: The MARADONA trial is designed to show equal results in anatomic and clinical success after one year, comparing MOCA with RFA. In our hypothesis MOCA has an equal anatomic and clinical success compared with RFA, with less post-procedural pain.

Trial registration: Clinicaltrials NCT01936168.

Figures

Figure 1
Figure 1
This figure illustrates the study design. A total of 460 patients will be randomized to radiofrequency ablation (N = 230) or mechanochemical endovenous ablation (N = 230). GSV, great saphenous vein.

References

    1. Callam MJ. Epidemiology of varicose veins. Br J Surg. 1994;81:167–173. doi: 10.1002/bjs.1800810204.
    1. Robertson L, Evans C, Fowkes FG. Epidemiology of chronic venous disease. Phlebology. 2008;23:103–111. doi: 10.1258/phleb.2007.007061.
    1. Maurins U, Hoffmann BH, Lösch C, Jöckel KH, Rabe E, Pannier F. Distribution and prevalence of reflux in the superficial and deep venous system in the general population – results from the Bonn Vein Study, Germany. J Vasc Surg. 2008;48:680–687. doi: 10.1016/j.jvs.2008.04.029.
    1. Evans C, Fowkes FG, Ruckley CV, Lee A. Prevalence of varicose veins and chronic venous insufficiency in men and women in the general population: Edinburgh Vein Study. J Epidemiol Community Health. 1999;53:149–153. doi: 10.1136/jech.53.3.149.
    1. Lee AJ, Evans C, Allan PL, Ruckley CV, Fowkes FG. Lifestyle factors and the risk of varicose veins: Edinburgh Vein Study. J Clin Epidemiol. 2003;564:171–179.
    1. Campbell B. Varicose veins and their management. BMJ. 2006;333:287–292. doi: 10.1136/bmj.333.7562.287.
    1. Sarin S, Scurr JH, Coleridge-Smith PD. Stripping of the long saphenous vein in the treatment of primary varicose veins. Br J Surg. 1994;81:1455–1458. doi: 10.1002/bjs.1800811017.
    1. Perrin MR, Guex JJ, Ruckley CV, de Palma RG, Royle JP, Eklof B, Nicolini P, Jantet G. Recurrent varices after surgery (REVAS): a consensus document. REVAS Group. Cardiovasc Surg. 2000;8:233–245. doi: 10.1016/S0967-2109(00)00021-1.
    1. Campbell WB, Vijay Kurnar A, Collin TW, Allington KL, Michaels JA. Outcome of varicose vein surgery at 10 years: clinical findings, symptoms and patient satisfaction. Ann R Coll Surg Engl. 2003;85:52–57. doi: 10.1308/003588403321001462.
    1. Perkins JM. Standard varicose vein surgery. Phlebology. 2009;24:34–41. doi: 10.1258/phleb.2009.09s004.
    1. Critchley G, Handa A, Maw A, Harvey A, Harvey MR, Corbett CR. Complications of varicose vein surgery. Ann R Coll Surg Engl. 1997;79:105–110.
    1. Van den Bos R, Arends L, Kockaert M, Neumann M, Nijsten T. Endovenous therapies of lower extremity varicosities: a meta-analysis. J Vasc Surg. 2009;49:230–239. doi: 10.1016/j.jvs.2008.06.030.
    1. Creton D, Pichot O, Sessa C, Proebstle TM. Radiofrequncy-powered segmental thermal obliteration carried out with the ClosureFast procedure: results at 1 year. Ann Vasc Surg. 2010;24:360–366. doi: 10.1016/j.avsg.2009.09.019.
    1. Ravi R, Trayler EA, Barrett DA, Diethrich EB. Endovenous thermal ablation of superficial venous insufficiency of the lower extremity: single-center experience with 3000 limbs treated in a 7-year period. J Endovasc Ther. 2009;16:500–505. doi: 10.1583/09-2750.1.
    1. Rasmussen LH, Lawaetz M, Bjoern L, Vennits B, Blemings A, Eklof B. Randomized clinical trial of endovenous laser ablation, radiofrequency ablation, foam sclerotherapy and surgical stripping for great saphenous varicose veins. Br J Surg. 2011;98:1079–1087. doi: 10.1002/bjs.7555.
    1. Subramonia S, Lees T. Randomized clinical trial of radiofrequency ablation or conventional ligation and stripping for great saphenous varicose veins. Br J Surg. 2010;97:328–336. doi: 10.1002/bjs.6867.
    1. Shepherd AC, Gohel MS, Lim CS, Hamish M, Davies AH. Pain following 980-nm endovenous laser ablation and segmental radiofrequency ablation for varicose veins: a prospective observational study. Vasc Endovascular Surg. 2010;44:212–216. doi: 10.1177/1538574409359337.
    1. Shepherd AC, Gohel MS, Brown LC, Metcalfe MJ, Hamish M, Davies AH. Randomized clinical trial of VNUS ClosureFAST radiofrequency ablation versus laser for varicose veins. Br J Surg. 2010;97:810–818. doi: 10.1002/bjs.7091.
    1. Elias S, Raines JK. Mechanochemical tumescentless endovenous ablation: final results of the initial clinical trial. Phlebology. 2012;27:67–72. doi: 10.1258/phleb.2011.010100.
    1. Elias S. Mechanochemical ablation (MOCA) of the great saphenous vein: 2-year results and recommendations from the initial human trial. National Harbor, MD: Presented at Society for Vascular Surgery Annual Meeting; 2012. Abstract SS21.
    1. Van Eekeren RR, Boersma D, Elias S, Holewijn S, Werson DA, De Vries JP, Reijnen MM. Endovenous mechanochemical ablation of great saphenous vein incompetence using the ClariVeinTM device: a safety study. J Endovasc Ther. 2011;18:328–334. doi: 10.1583/11-3394.1.
    1. Boersma D, Van Eekeren RR, Werson DA, Van der Waal RI, Reijnen MM, De Vries JP. Mechanochemical endovenous ablation of small saphenous vein insufficiency using the ClariVein device: one-year results of a prospective series. Eur J Vasc Endovasc Surg. 2013;45:299–303. doi: 10.1016/j.ejvs.2012.12.004.
    1. Bishawi M, Bernstein R, Boter M, Draughn D, Gould C, Hamilton C, Koziarski J. Mechanochemical ablation in patients with chronic venous disease: a prospective multicenter report. Phlebology. 2013. epub ahead of print. doi: 10.1177/0268355513495830.
    1. Van Eekeren RR, Boersma D, Konijn V, De Vries JP, Reijnen MM. Postoperative pain and early quality of life after radiofrequency ablation and mechanochemical endovenous ablation of incompetent great saphenous veins. J Vasc Surg. 2013;57:445–450. doi: 10.1016/j.jvs.2012.07.049.
    1. Kistner RL, Eklof B, Masuda EM. Diagnosis of chronic venous disease of the lower extremities: the “CEAP” classification. Mayo Clin Proc. 1996;71:338–345. doi: 10.4065/71.4.338.
    1. Rutherford RB, Padberg FT, Comerota AJ, Kistner RL, Meissner MH, Moneta GL. Venous severity scoring: an adjunct to venous outcome assessment. J Vasc Surg. 2000;31:1307–1312. doi: 10.1067/mva.2000.107094.
    1. Klem TM, Sybrandy JE, Wittens CH, Essink Bot ML. Reliability and validity of the Dutch translated Aberdeen Varicose Vein Questionnaire. Eur J Vasc Endovasc Surg. 2009;37:232–238. doi: 10.1016/j.ejvs.2008.08.025.
    1. Proebstle TM, Alm J, Göckeritz O, Wenzel C, Noppeney T, Lebard C, Pichot O, Sessa C, Creton D. Three-year European follouw-up of endovenous radiofrequency-powered segmental thermal ablation of the great saphenous vein with or without treatment of calf varicosities. J Vasc Surg. 2011;54:146–152. doi: 10.1016/j.jvs.2010.12.051.
    1. Goode SD, Chowdhury A, Crockett M, Beech A, Simpson R, Richards T, Braithwaite BD. Laser and radiofrequency ablation study (LARA) study: a randomized study comparing radiofrequency ablation and endovenous laser ablation (810 nm) Eur J Vasc Endovasc Surg. 2010;40:246–253. doi: 10.1016/j.ejvs.2010.02.026.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren